Form 8-K - Current report:
SEC Accession No. 0001835268-25-000056
Filing Date
2025-09-16
Accepted
2025-09-16 09:02:18
Documents
12
Period of Report
2025-09-16
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K cntb-20250916.htm   iXBRL 8-K 24481
  Complete submission text file 0001835268-25-000056.txt   142861

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntb-20250916.xsd EX-101.SCH 1806
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntb-20250916_lab.xml EX-101.LAB 22498
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntb-20250916_pre.xml EX-101.PRE 13245
15 EXTRACTED XBRL INSTANCE DOCUMENT cntb-20250916_htm.xml XML 2828
Mailing Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130
Business Address 3580 CARMEL MOUNTAIN ROAD, SUITE 200 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40212 | Film No.: 251315977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)